Literature DB >> 7028539

Diabetes and atherosclerosis: an overview.

G Steiner.   

Abstract

Atherosclerosis is the most common complication of diabetes. Epidemiologic and pathophysiologic evidence suggest a number of possible reasons for this. They include alterations in lipoproteins, platelets, soluble clotting factors, the balance of prostacyclin-thromboxane, blood pressure regulation, and arterial smooth muscle cell metabolism and proliferation. Many of these alterations may accompany hyperinsulinemia and may account for the recent evidence that hyperinsulinemia is a risk factor for atherosclerosis. Advances in this area will require the recognition that neither diabetes nor atherosclerosis are single disorders. Furthermore, new approaches are needed to study these disorders in which there may be many years of very subtle changes before any end point is apparent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028539     DOI: 10.2337/diab.30.2.s1

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  Endothelial function. General considerations.

Authors:  H Haller
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  Diabetes and atherosclerosis. Metabolic links.

Authors:  G Steiner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Effects of insulin on the disposal of 14C-labelled very low density lipoprotein triglycerides in intact and hepatectomized rats.

Authors:  J Argilés; E Herrera
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

5.  Beneficial effects of a mild exercise programme on hypertriglyceridaemia, glucose tolerance and hyperinsulinaemia in obese patients.

Authors:  R I Misbin
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

6.  Platelet aggregation after strict metabolic control using the artificial pancreas.

Authors:  D Giugliano; L Misso; A Tirelli; L Coppola; P Di Pinto; R Torella
Journal:  Diabetologia       Date:  1982-12       Impact factor: 10.122

Review 7.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

Review 8.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

9.  Lack of a persistent reduction in serum lipid and apoprotein levels in insulin-dependent diabetic patients receiving intensified insulin treatment.

Authors:  R B Goldberg; M L Reeves; D E Seigler; E A Ryan; N Miller; S L Hsia; J S Skyler
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun

10.  Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects.

Authors:  Lars Maegdefessel; Axel Schlitt; Susanna Pippig; Bernhard Schwaab; Kerstin Fingscheidt; Uwe Raaz; Michael Buerke; Harald Loppnow
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.